DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · IEX Real-Time Price · USD
2.600
+0.070 (2.77%)
At close: Apr 26, 2024, 3:57 PM
2.580
-0.020 (-0.77%)
After-hours: Apr 26, 2024, 4:00 PM EDT
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $97.55 million as of April 26, 2024. Its market cap has increased by 114.40% in one year.
Market Cap
97.55M
Enterprise Value
43.91M
1-Year Change
114.40%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $97.55M, an increase of 165.81%. That is a compound annual growth rate of 19.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 93.00M | 1.20% |
Apr 23, 2024 | 91.90M | -3.57% |
Apr 22, 2024 | 95.30M | 5.07% |
Apr 19, 2024 | 90.70M | -4.02% |
Apr 18, 2024 | 94.50M | -4.26% |
Apr 17, 2024 | 98.70M | 9.67% |
Apr 16, 2024 | 90.00M | -0.77% |
Apr 15, 2024 | 90.70M | -1.63% |
Apr 12, 2024 | 92.20M | -4.36% |
Apr 11, 2024 | 96.40M | -4.17% |
Apr 10, 2024 | 100.60M | -2.24% |
Apr 9, 2024 | 102.90M | -2.46% |
Apr 8, 2024 | 105.50M | -6.72% |
Apr 5, 2024 | 113.10M | 0.98% |
Apr 4, 2024 | 112.00M | 5.36% |
Apr 3, 2024 | 106.30M | 2.61% |
Apr 2, 2024 | 103.60M | - |
Apr 1, 2024 | 103.60M | -1.43% |
Mar 28, 2024 | 105.10M | 4.47% |
Mar 27, 2024 | 100.60M | -2.52% |
Mar 26, 2024 | 103.20M | 1.47% |
Mar 25, 2024 | 101.70M | -2.59% |
Mar 22, 2024 | 104.40M | 2.25% |
Mar 21, 2024 | 102.10M | -2.85% |
Mar 20, 2024 | 105.10M | -1.78% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Abeona Therapeutics | 93.28M |
ProPhase Labs | 93.11M |
PMV Pharmaceuticals | 92.86M |
Elutia | 92.79M |
Allakos | 92.27M |
SELLAS Life Sciences Group | 91.72M |
Armata Pharmaceuticals | 91.46M |
Milestone Pharmaceuticals | 90.35M |